文献速递肝胆胰外科

微创肝脏手术项目发展的「受益者是谁」评估:左半肝与右半肝切除术中开腹与腹腔镜入路的差异获益分析

A "cui prodest" evaluation on the development of a minimally invasive liver surgery program: a differential benefit analysis of open and laparoscopic approach for left and right hemihepatectomies.
PubMed 文献 · Surg Endosc · 2023-08-30

这项单中心回顾性研究纳入2004年1月至2021年12月所有半肝切除术,用倾向评分1:1匹配微创与开腹病例,比较左、右半肝切除术的差异获益。风险校正分析显示,右半肝组微创较开腹在失血量、并发症率和住院时间上的改善均大于左半肝组,差异获益分别为200 mL、6.8%和2天(均p<0.05)。作者结论认为微创肝脏手术在左右半肝切除中均改善临床结局,但右半肝获益更大,微创项目应覆盖尽可能广的肝切除范围。

要点

  • 风险校正分析中,右半肝组微创较开腹的失血量降幅大于左半肝组,差异获益200 mL(p<0.05)。
  • 并发症率降幅右半肝组大于左半肝组,差异获益6.8%(p<0.05)。
  • 住院时间降幅右半肝组大于左半肝组,差异获益2天(p<0.05)。

核心结论

  • 微创肝脏手术在左、右半肝切除术中均与改善的临床结局相关,但腹腔镜在右半肝切除术中提供的获益更大,即技术难度更高的手术获益更明显;微创肝脏手术项目应覆盖尽可能广的肝切除范围以确保腹腔镜技术的全部获益。

研究设计与样本

  • 单中心回顾性研究,纳入2004年1月至2021年12月机构数据库中所有半肝切除术病例。
  • 采用倾向评分方法,在左半肝切除术组和右半肝切除术组内分别以1:1比例匹配微创与开腹配对,以校正潜在选择偏倚。
  • 差异获益在纯分析(含中转开腹病例)和风险校正分析(从腹腔镜序列中排除中转开腹)两种方式下评估。

主要发现

  • 风险校正差异获益分析显示,右半肝组微创较开腹的失血量降幅大于左半肝组(∆失血量分别为-150和-350;差异获益200 mL,p<0.05)。
  • 右半肝组微创较开腹的并发症率降幅大于左半肝组(∆并发症率分别为-11.3%和-18.1%;差异获益6.8%,p<0.05)。
  • 右半肝组微创较开腹的住院时间降幅大于左半肝组(∆住院时间分别为-1天和-3天;差异获益2天,p<0.05)。

临床怎么用

  • 作者认为微创肝脏手术项目应覆盖尽可能广的肝切除范围,以确保腹腔镜技术的全部获益。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The correlation between technical feasibility and short-term clinical advantage provided by laparoscopic over open technique for major hepatectomies is unclear. This monocentric retrospective study investigates the possible differences in the benefit provided by minimally invasive approach between left and right hepatectomy, deepening the concept of differential benefit in the setting of anatomical major resections. METHODS: All hemihepatectomies performed from January 2004 to December 2021 were identified in the institutional database. A propensity score method was used to match minimal invasive (MILS) and open pairs in the left hemihepatectomies (LH) and right hemihepatectomies (RH) groups with a 1:1 ratio to adjust any potential selection bias. The differential benefit for left and right hepatectomy provided by laparoscopic over open technique was evaluated in a pure analysis (i.e., including cases converted to open) and a risk-adjusted analysis (i.e., after excluding open conversion from the laparoscopic series). RESULTS: The analysis of the risk-adjusted differential benefit demonstrated better result of the MILS in the RH group than in the LH group, in terms of blood loss (∆ blood loss - 150 and - 350, respectively; differential benefit: 200 mL, p < 0.05), morbidity (∆ rate of morbidity - 11.3% and - 18.1%, respectively; differential benefit: 6.8%, p < 0.05) and length of stay, LOS (∆ LOS - 1 day and - 3 days, respectively; differential benefit: 2 days, p < 0.05). CONCLUSION: While MILS is associated with improved clinical outcomes both in left and right hepatectomy procedures, the greater advantage provided by laparoscopy was documented in patients undergoing right hepatectomy, i.e. for more technically demanding procedures. A MILS program should include the broadest range of liver resections to ensure the full benefits of the laparoscopic technique.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Pascale MM, Ratti F, Cipriani F, et al. A "cui prodest" evaluation on the development of a minimally invasive liver surgery program: a differential benefit analysis of open and laparoscopic approach for left and right hemihepatectomies. Surg Endosc. 2023. PMID: 37648797. doi:10.1007/s00464-023-10382-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。